Integrated Core Strategies (Asia) Pte. Ltd. 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-26 4:34 pm Purchase | 2022-09-16 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Integrated Core Strategies (Asia) Pte. Ltd. | 759,112 4.400% | 759,112 (New Position) | Filing |
| 2022-09-22 4:02 pm Purchase | 2022-09-16 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Integrated Core Strategies (Asia) Pte. Ltd. | 759,112 4.400% | 759,112 (New Position) | Filing |